Platelet infusions are administered through standard blood transfusion tubing with a built-in filter, typically over 15 to 30 minutes per unit. The process involves careful product verification, continuous patient monitoring, and specific equipment and handling requirements that distinguish platelets from other blood products. Here’s what the full procedure looks like from start to finish.
How Platelets Are Stored Before Infusion
Platelets are unique among blood products because they must be stored at room temperature, specifically between 20 and 24 °C (68 to 75 °F). Most other blood components are refrigerated, but platelets lose their function when chilled. At this warmer temperature, the bags require continuous gentle agitation on a special rocking device throughout storage. This constant movement prevents the platelets from clumping together and keeps the pH above 6.2, which is essential for the cells to remain viable.
Platelets can also be stored at 1 to 6 °C, in which case agitation is optional, but room-temperature storage with agitation is the standard practice. Because of these requirements, platelets have a short shelf life compared to red blood cells, typically just five days. This means there’s often urgency once a unit is issued from the blood bank.
ABO and Rh Compatibility
Platelets carry ABO antigens on their surface and are collected in plasma that contains ABO antibodies matching the donor’s blood type. In an ideal scenario, patients receive ABO-identical platelets. In practice, though, out-of-group platelet transfusions are common and generally uneventful. Unlike red blood cell transfusions, there is no risk of the severe intravascular hemolysis that occurs when mismatched red cells are given. The main concern with ABO-incompatible platelets is that antibodies in the donor plasma could theoretically cause some destruction of the recipient’s red blood cells, and the platelets themselves may not last as long in circulation.
Platelets do not carry Rh antigens, but each unit contains trace amounts of red blood cells or red cell fragments from the donor. When platelets from an Rh-positive donor go to an Rh-negative recipient, there is a small risk of triggering Rh antibody formation. This matters most for women of childbearing age, where Rh sensitization could affect future pregnancies. Only products containing more than 2 mL of incompatible red cells require a formal crossmatch.
Equipment and Setup
Platelet infusions use a standard blood transfusion set with an inline filter. The filter has a pore size of 170 to 260 micrometers, large enough to let platelets pass through freely while trapping fibrin clots and cellular debris that could cause problems in the bloodstream. This is the same type of tubing used for red blood cell transfusions.
The tubing can be primed with either normal saline or the platelet product itself. No other IV fluids should run through the same line during the transfusion. Calcium-containing solutions like lactated Ringer’s, for instance, can cause clotting in the tubing and must be avoided.
Bedside Verification Before Starting
The most critical safety step in any transfusion is confirming that the right product is going to the right patient. Transfusion errors from misidentification remain one of the most preventable yet dangerous mistakes in hospital settings. Standard protocol requires a two-person check at the bedside, where both individuals verbally and visually verify the patient’s identity against the blood product label.
The verification process covers the patient’s full name, date of birth, hospital identification number, blood group, the product lot number, the collection date, and the results of any compatibility testing. The patient is asked to state their own name and date of birth rather than simply confirming what someone reads to them. Many hospitals now use electronic systems with barcode scanning: the transfusionist scans their own ID badge, the patient’s wristband, and the blood unit label in sequence. The system cross-references all three and gives a go or no-go signal before the infusion can begin.
Monitoring During the Infusion
Vital signs should be recorded at a minimum of three time points: before the transfusion starts, 15 minutes after starting, and at completion. This three-checkpoint approach has been shown to be effective for catching the signs and symptoms of transfusion reactions. Some institutions add hourly checks for longer transfusions or more frequent monitoring during the first hour.
The first 15 minutes are the highest-risk window. The transfusionist should stay with or near the patient during this period, watching for any early signs of a reaction such as fever, chills, hives, itching, or difficulty breathing. If the patient tolerates the first 15 minutes without incident, the infusion rate can typically be increased to whatever was specified in the clinical order. After the transfusion is complete, periodic monitoring for 4 to 6 hours is recommended, since some reactions can present on a delayed basis.
What Happens if There’s a Reaction
The two most common reactions to platelet transfusions are febrile non-hemolytic reactions and allergic reactions. Febrile reactions cause a temperature spike, sometimes with chills and general discomfort. Allergic reactions typically present as hives, itching, or mild skin flushing.
For any suspected reaction, the first step is always the same: stop the transfusion immediately and keep the IV line open with normal saline. Mild febrile reactions can often be managed with a standard dose of acetaminophen. Mild allergic reactions may be treated with an antihistamine, and the transfusion can sometimes be resumed at a slower rate once symptoms resolve. More severe reactions involving breathing difficulty, a significant drop in blood pressure, or chest pain require a more urgent clinical response and the transfusion is not restarted.
Modern processing techniques, particularly the removal of white blood cells from donated blood before storage, have significantly reduced the rate of febrile reactions. Allergic reactions, however, have not been affected by this change and remain the more commonly reported issue with platelet transfusions specifically.
Checking Whether the Transfusion Worked
After the infusion is complete, a blood draw is typically done within 10 to 60 minutes to measure the patient’s new platelet count. The simplest way to evaluate success is to calculate the corrected count increment, or CCI. This formula accounts for both the patient’s body size and the number of platelets transfused, making it more reliable than looking at the raw count change alone.
The calculation works like this: multiply the platelet count increase (per microliter) by the patient’s body surface area (in square meters), then divide by the number of platelets transfused. A CCI of 7,500 or higher within the first hour indicates a successful transfusion, representing roughly 20 to 30 percent platelet recovery. As a practical example, if a patient with a body surface area of 1.8 square meters receives a single-donor platelet unit containing about 3 × 10¹¹ platelets and their count rises by 20,000 per microliter, the CCI would be 12,000, a good result.
When the CCI falls below 7,500 on two consecutive transfusions, the patient is considered platelet refractory. This can happen for immune reasons, such as antibodies against donor platelet proteins, or non-immune causes like fever, infection, or an enlarged spleen consuming platelets faster than they can circulate. Identifying the cause of refractoriness determines what kind of platelet product will be selected for future transfusions.